KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 65 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,010,860 | -23.8% | 208,812 | -28.8% | 0.00% | -100.0% |
| Q2 2023 | $2,639,799 | +21.9% | 293,311 | +6.5% | 0.00% | – |
| Q1 2023 | $2,165,304 | -7.3% | 275,484 | -20.3% | 0.00% | -100.0% |
| Q4 2022 | $2,336,966 | -52.4% | 345,705 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $4,907,000 | +65.5% | 338,180 | +12.2% | 0.00% | 0.0% |
| Q2 2022 | $2,965,000 | +20.7% | 301,275 | +80.7% | 0.00% | 0.0% |
| Q1 2022 | $2,457,000 | +86.8% | 166,705 | +67.7% | 0.00% | – |
| Q4 2021 | $1,315,000 | +8.7% | 99,431 | +43.5% | 0.00% | – |
| Q3 2021 | $1,210,000 | +59.8% | 69,295 | +119.2% | 0.00% | – |
| Q2 2021 | $757,000 | -46.0% | 31,610 | -42.1% | 0.00% | – |
| Q1 2021 | $1,403,000 | +598.0% | 54,599 | +416.5% | 0.00% | – |
| Q4 2020 | $201,000 | -54.8% | 10,570 | -71.3% | 0.00% | – |
| Q2 2020 | $445,000 | +23.6% | 36,781 | +82.0% | 0.00% | – |
| Q4 2019 | $360,000 | -34.1% | 20,213 | -57.1% | 0.00% | – |
| Q3 2019 | $546,000 | +17.9% | 47,094 | +125.2% | 0.00% | – |
| Q2 2019 | $463,000 | -57.2% | 20,913 | -44.7% | 0.00% | – |
| Q1 2019 | $1,082,000 | +616.6% | 37,790 | +143.4% | 0.00% | – |
| Q4 2017 | $151,000 | – | 15,528 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |